CWG
EGRX

C WorldWide Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

C WorldWide Group’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-18,102
Closed -$1.25M – 133
2018
Q3 		$1.25M Sell
18,102
-19,968
-52% -$1.51M 0.02% 105
2018
Q2 		$2.88M Buy
38,070
+7,141
+23% +$449K 0.04% 87
2018
Q1 		$1.63M Sell
30,929
-5,398
-15% -$314K 0.03% 87
2017
Q4 		$1.94M Sell
36,327
-27,715
-43% -$1.54M 0.03% 86
2017
Q3 		$3.82M Buy
64,042
+15,301
+31% +$926K 0.05% 75
2017
Q2 		$3.85M Sell
48,741
-16,344
-25% -$1.34M 0.06% 71
2017
Q1 		$5.4M Buy
65,085
+11,485
+21% +$854K 0.09% 51
2016
Q4 		$4.25M Sell
53,600
-29,807
-36% -$2.17M 0.08% 60
2016
Q3 		$5.84M Sell
83,407
-14,000
-14% -$776K 0.1% 46
2016
Q2 		$3.78M Sell
97,407
-101,500
-51% -$4.23M 0.07% 50
2016
Q1 		$8.06M Sell
198,907
-20,000
-9% -$1.27M 0.16% 41
2015
Q4 		$19.4M Sell
218,907
-55,000
-20% -$4.34M 0.34% 31
2015
Q3 		$20.3M Sell
273,907
-5,500
-2% -$458K 0.34% 29
2015
Q2 		$22.6M Buy
279,407
+145,000
+108% +$9.45M 0.32% 30
2015
Q1 		$5.63M Buy
134,407
+40,000
+42% +$1.13M 0.08% 54
2014
Q4 		$1.46M Sell
94,407
-45,593
-33% -$582K 0.02% 79
2014
Q3 		$1.72M Buy
+140,000
New +$1.74M 0.03% 81

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

C WorldWide Group's EGRX Position: Q4 2018 in Review

C WorldWide Group sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2018, closing a stake of 18,102 shares — an estimated $1.25M sold.

C WorldWide Group first reported a position in EGRX in Q3 2014 and held it in 17 quarters. The position peaked at $22.6M in Q2 2015. 182 funds tracked by Wall St. Rank hold EGRX as of Q4 2018.

  • C WorldWide Group reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • C WorldWide Group sold 18,102 Eagle Pharmaceuticals, Inc. shares in Q4 2018, an estimated $1.25M.
  • C WorldWide Group first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2014 and held it in 17 quarters.
  • C WorldWide Group's Eagle Pharmaceuticals, Inc. position peaked at $22.6M in Q2 2015.
  • 182 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2018.

Based on C WorldWide Group's 13F filing for Q4 2018, filed 12 Feb 2019.